[HTML][HTML] Proteomics technologies for cancer liquid biopsies
Alterations in DNAs could not reveal what happened in proteins. The accumulated
alterations of DNAs would change the manifestation of proteins. Therefore, as is the case in …
alterations of DNAs would change the manifestation of proteins. Therefore, as is the case in …
[HTML][HTML] Multifunctional iron oxide magnetic nanoparticles for biomedical applications: A review
Due to their good magnetic properties, excellent biocompatibility, and low price, magnetic
iron oxide nanoparticles (IONPs) are the most commonly used magnetic nanomaterials and …
iron oxide nanoparticles (IONPs) are the most commonly used magnetic nanomaterials and …
Functional ligands for improving anticancer drug therapy: current status and applications to drug delivery systems
R Bajracharya, JG Song, BR Patil, SH Lee, HM Noh… - Drug Delivery, 2022 - Taylor & Francis
Conventional chemotherapy lacking target selectivity often leads to severe side effects,
limiting the effectiveness of chemotherapy. Therefore, drug delivery systems ensuring both …
limiting the effectiveness of chemotherapy. Therefore, drug delivery systems ensuring both …
[HTML][HTML] Liquid biopsies, novel approaches and future directions
A Armakolas, M Kotsari, J Koskinas - Cancers, 2023 - mdpi.com
Simple Summary The gold standard for detecting cancer and profiling tumors is tissue
biopsies. Despite this, tissue biopsies have been associated with many limitations leading to …
biopsies. Despite this, tissue biopsies have been associated with many limitations leading to …
Design and synthesis of DNA hydrogel based on EXPAR and CRISPR/Cas14a for ultrasensitive detection of creatine kinase MB
M Chen, J Zhang, Y Peng, J Bai, S Li, D Han… - Biosensors and …, 2022 - Elsevier
Clustered regularly interspaced short palindromic repeats (CRISPR)/Cas systems exhibit
significant potential in developing biosensing technology due to their collateral cleavage …
significant potential in developing biosensing technology due to their collateral cleavage …
[HTML][HTML] Fiber-type shifting in sarcopenia of old age: proteomic profiling of the contractile apparatus of skeletal muscles
P Dowling, S Gargan, D Swandulla… - International Journal of …, 2023 - mdpi.com
The progressive loss of skeletal muscle mass and concomitant reduction in contractile
strength plays a central role in frailty syndrome. Age-related neuronal impairments are …
strength plays a central role in frailty syndrome. Age-related neuronal impairments are …
[HTML][HTML] Non-small cell lung carcinoma (NSCLC): Implications on molecular pathology and advances in early diagnostics and therapeutics
Continuous revision of the histologic and stage-wise classification of lung cancer by the
World Health Organization (WHO) provides the foundation for therapeutic advances by …
World Health Organization (WHO) provides the foundation for therapeutic advances by …
[HTML][HTML] Biomarkers in neurodegenerative diseases: proteomics spotlight on ALS and Parkinson's disease
R Raghunathan, K Turajane, LC Wong - International Journal of …, 2022 - mdpi.com
Neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS) and Parkinson's
disease (PD) are both characterized by pathogenic protein aggregates that correlate with …
disease (PD) are both characterized by pathogenic protein aggregates that correlate with …
Aptamers: an emerging navigation tool of therapeutic agents for targeted cancer therapy
C Yang, Y Jiang, SH Hao, XY Yan… - Journal of materials …, 2022 - pubs.rsc.org
Chemotherapeutic agents have been used for the treatment of numerous cancers, but due to
poor selectivity and severe systemic side effects, their clinical application is limited. Single …
poor selectivity and severe systemic side effects, their clinical application is limited. Single …
Clinical applications of plasma proteomics and peptidomics: Towards precision medicine
In the context of precision medicine, disease treatment requires individualized strategies
based on the underlying molecular characteristics to overcome therapeutic challenges …
based on the underlying molecular characteristics to overcome therapeutic challenges …